EPZ015666 |
A potent, selective, and orally bioavailable inhibitor of PRMT5 (Ki = 5 nM… |
5 mg |
17285-5 |
More Info
|
EPZ020411 |
An inhibitor of PRMT6 (IC50 = 10 nM) that less potently targets PRMT1 and… |
1 mg |
19160-1 |
More Info
|
EPZ020411 |
An inhibitor of PRMT6 (IC50 = 10 nM) that less potently targets PRMT1 and… |
10 mg |
19160-10 |
More Info
|
EPZ020411 |
An inhibitor of PRMT6 (IC50 = 10 nM) that less potently targets PRMT1 and… |
25 mg |
19160-25 |
More Info
|
EPZ020411 |
An inhibitor of PRMT6 (IC50 = 10 nM) that less potently targets PRMT1 and… |
5 mg |
19160-5 |
More Info
|
EPZ5676 |
A highly potent and selective inhibitor of DOT1L histone methyltransferase… |
1 mg |
16175-1 |
More Info
|
EPZ5676 |
A highly potent and selective inhibitor of DOT1L histone methyltransferase… |
10 mg |
16175-10 |
More Info
|
EPZ5676 |
A highly potent and selective inhibitor of DOT1L histone methyltransferase… |
25 mg |
16175-25 |
More Info
|
EPZ5676 |
A highly potent and selective inhibitor of DOT1L histone methyltransferase… |
5 mg |
16175-5 |
More Info
|
EPZ6438 |
An orally bioavailable, selective inhibitor of EZH2 (Ki = 2.5 nM); blocks… |
1 mg |
16174-1 |
More Info
|
EPZ6438 |
An orally bioavailable, selective inhibitor of EZH2 (Ki = 2.5 nM); blocks… |
10 mg |
16174-10 |
More Info
|
EPZ6438 |
An orally bioavailable, selective inhibitor of EZH2 (Ki = 2.5 nM); blocks… |
5 mg |
16174-5 |
More Info
|
EPZ6438 |
An orally bioavailable, selective inhibitor of EZH2 (Ki = 2.5 nM); blocks… |
50 mg |
16174-50 |
More Info
|
EPZ004777 (formate) |
A potent DOT1L inhibitor (IC50 = 400 pM) that selectively kills (MLL) cell… |
1 mg |
16173-1 |
More Info
|
EPZ004777 (formate) |
A potent DOT1L inhibitor (IC50 = 400 pM) that selectively kills (MLL) cell… |
10 mg |
16173-10 |
More Info
|
EPZ004777 (formate) |
A potent DOT1L inhibitor (IC50 = 400 pM) that selectively kills (MLL) cell… |
5 mg |
16173-5 |
More Info
|
EPZ004777 (formate) |
A potent DOT1L inhibitor (IC50 = 400 pM) that selectively kills (MLL) cell… |
500 µg |
16173-500 |
More Info
|
Equilenin |
An equine estrogen; has no effect on eNOS activity or expression and does… |
1 mg |
23322-1 |
More Info
|
Equilenin |
An equine estrogen; has no effect on eNOS activity or expression and does… |
500 µg |
23322-500 |
More Info
|
Equisetin |
An HIV-1 integrase inhibitor; inhibits Dnp-stimulated ATPase activity of r… |
1 mg |
18196-1 |
More Info
|
Equisetin |
An HIV-1 integrase inhibitor; inhibits Dnp-stimulated ATPase activity of r… |
5 mg |
18196-5 |
More Info
|
ER-819762 |
An antagonist of EP4 (IC50 = 70 nM); selective for EP4 over EP1, EP2, and… |
1 mg |
10531-1 |
More Info
|
ER-819762 |
An antagonist of EP4 (IC50 = 70 nM); selective for EP4 over EP1, EP2, and… |
10 mg |
10531-10 |
More Info
|
ER-819762 |
An antagonist of EP4 (IC50 = 70 nM); selective for EP4 over EP1, EP2, and… |
5 mg |
10531-5 |
More Info
|
Erastin |
A ferroptosis inducer; induces ferroptotic cell death in vitro, an effect… |
1 mg |
17754-1 |
More Info
|